||
基因工程化PD1蛋白制剂用于肿瘤免疫治疗研究
https://www.ebiotrade.com/newsf/2024-1/20240116063925566.htm
http://www.pubmedplus.cn/P/SearchQuickResult?wd=cd94935f-5d0e-488b-845b-4fbb9f8ec4ab
01. | Humans | 96 篇 | 49.741% |
02. | Animals | 90 篇 | 46.632% |
03. | Immunotherapy | 75 篇 | 38.860% |
04. | Mice | 72 篇 | 37.306% |
05. | Neoplasms | 48 篇 | 24.870% |
06. | Cancer Vaccines | 44 篇 | 22.798% |
07. | Cell Line, Tumor | 41 篇 | 21.244% |
08. | Dendritic Cells | 38 篇 | 19.689% |
09. | Mice, Inbred C57BL | 30 篇 | 15.544% |
10. | Female | 25 篇 | 12.953% |
(37)
(12)
(8)
(6)
(4)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
https://fx.wanfangdata.com.cn/keytrends/detail?theme_name=PD1
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-5-13 15:26
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社